Background Shifting from cytology to human papillomavirus (HPV)-based cervical cancer
screening will initially increase colposcopy referrals. The anticipated impact on health …

Objective To estimate the impact of implementing primary human papilloma virus liquid-
based cytology (LBC) screening on four-year rates of referral for colposcopy in the British …

Introduction Human papillomavirus (HPV) testing as the primary cervical cancer screening
method is implemented in several countries. We report data from the first round of a large …

Human papillomavirus (HPV) testing is more sensitive than cytology; some cervical cancer
prevention programs will switch from cytology to carcinogenic HPV test‐based screening …

Background Human papillomavirus (HPV) testing is increasingly used as the primary
cervical cancer screening test. In a large pilot implementation, we compared participation …

Background Randomized controlled trials have shown a higher sensitivity and longer
negative predictive value of high-risk human papillomavirus (HPV) testing than cytology for …

Background Colposcopy, currently included in WHO recommendations as an option to triage
human papillomavirus (HPV)-positive women, remains as the reference standard to guide …

Since the US Food and Drug Administration (FDA) approval of the first human
papillomavirus (HPV) test for primary cervical cancer screening in April, questions regarding …

Objectives: This study investigates potential colposcopy referral rates, as per the latest
American Society for Colposcopy and Cervical Pathology recommendations, following the …

Background Randomised controlled trials showed human papillomavirus (HPV)-based
screening leads to a significant reduction in cervical cancer incidence compared with …